`
`NOTE: This order is nonprecedential.
`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`NOVARTIS AG,
`Plaintiffs-Appellants
`
`v.
`
`BRECKENRIDGE PHARMACEUTICAL INC., WEST-
`WARD PHARMACEUTICALS INTERNATIONAL
`LIMITED, PAR PHARMACEUTICAL, INC.,
`Defendants-Appellees
`______________________
`
`2017-2173, 2017-2175, 2017-2176, 2017-2178, 2017-2179,
`2017-2180, 2017-2182, 2017-2183, 2017-2184
`______________________
`
`Appeals from the United States District Court for the
`District of Delaware in Nos. 1:14-cv-01043-RGA, 1:14-cv-
`01196-RGA, 1:14-cv-01289-RGA, 1:14-cv-01494-RGA, 1:14-
`cv-01508-RGA, 1:15-cv-00078-RGA, 1:15-cv-00128-RGA,
`1:16-cv-00431-RGA, 1:17-cv-00389-RGA, 1:17-cv-00420-
`RGA, Judge Richard G. Andrews.
`______________________
`
`ON PETITION FOR REHEARING EN BANC
`______________________
`
`Before PROST, Chief Judge, NEWMAN, LOURIE, DYK,
`O’MALLEY, REYNA, WALLACH, TARANTO, CHEN, HUGHES,
`and STOLL, Circuit Judges*.
`
`
`
`Case 1:16-cv-00431-RGA Document 101 Filed 02/08/19 Page 2 of 2 PageID #: 837
`
`
`
` 2
`
` NOVARTIS PHARMACEUTICALS CORP v. BRECKENRIDGE
`PHARMACEUTICAL
`
` PER CURIAM.
`
`O R D E R
`Appellee West-Ward Pharmaceuticals International
`
`Limited filed a petition for rehearing en banc. The petition
`was first referred as a petition for rehearing to the panel
`that heard the appeal, and thereafter the petition for re-
`hearing en banc was referred to the circuit judges who are
`in regular active service.
` Upon consideration thereof,
`
`IT IS ORDERED THAT:
`The petition for panel rehearing is denied.
`The petition for rehearing en banc is denied.
`The mandate of the court will issue on February 15,
`2019.
`
`
`
`
`
`
`
`
`
`
`
` FOR THE COURT
`
`
`
`
`
`
`
`February 8, 2019
` Date
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /s/ Peter R. Marksteiner
` Peter R. Marksteiner
`
` Clerk of Court
`
`
`* Circuit Judge Moore did not participate.
`
`